IM Cannabis Corp. (IMCC)
3.25
-0.16
(-4.69%)
USD |
NASDAQ |
Aug 31, 14:09
IM Cannabis Enterprise Value : 64.05M for Aug. 28, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 64.05M |
| August 27, 2026 | 72.69M |
| August 26, 2026 | 62.94M |
| August 25, 2026 | 61.67M |
| August 24, 2026 | 62.01M |
| August 21, 2026 | 63.63M |
| August 20, 2026 | 64.26M |
| August 19, 2026 | 60.30M |
| August 18, 2026 | 59.76M |
| August 17, 2026 | 59.81M |
| August 14, 2026 | 68.18M |
| August 13, 2026 | 72.04M |
| August 12, 2026 | 72.04M |
| August 11, 2026 | 73.16M |
| August 10, 2026 | 72.04M |
| August 07, 2026 | 69.45M |
| August 06, 2026 | 68.81M |
| August 05, 2026 | 69.59M |
| August 04, 2026 | 70.57M |
| August 03, 2026 | 69.94M |
| July 31, 2026 | 65.09M |
| July 30, 2026 | 64.95M |
| July 29, 2026 | 61.33M |
| July 28, 2026 | 61.67M |
| July 27, 2026 | 60.99M |
| Date | Value |
|---|---|
| July 24, 2026 | 67.59M |
| July 23, 2026 | 73.56M |
| July 22, 2026 | 75.07M |
| July 21, 2026 | 75.41M |
| July 20, 2026 | 73.46M |
| July 17, 2026 | 78.84M |
| July 16, 2026 | 78.10M |
| July 15, 2026 | 80.84M |
| July 14, 2026 | 77.66M |
| July 13, 2026 | 80.60M |
| July 10, 2026 | 84.27M |
| July 09, 2026 | 87.25M |
| July 08, 2026 | 84.27M |
| July 07, 2026 | 84.27M |
| July 06, 2026 | 83.68M |
| July 02, 2026 | 83.29M |
| July 01, 2026 | 84.32M |
| June 30, 2026 | 90.82M |
| June 29, 2026 | 38.07M |
| June 26, 2026 | 36.37M |
| June 25, 2026 | 36.19M |
| June 24, 2026 | 39.77M |
| June 23, 2026 | 40.40M |
| June 22, 2026 | 42.74M |
| June 18, 2026 | 43.65M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| InterCure Ltd. | 80.75M |
| Teva Pharmaceutical Industries Ltd. | 55.68B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 137.64M |
| Purple Biotech Ltd. | -3.310M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.168M |
| Revenue (Quarterly) | 5.482M |
| Total Expenses (Quarterly) | 8.632M |
| EPS Diluted (Quarterly) | -0.3399 |
| Gross Profit Margin (Quarterly) | 19.83% |
| Profit Margin (Quarterly) | -57.78% |
| Earnings Yield | -64.42% |
| Normalized Earnings Yield | -64.42 |